- Home
- CBFV vs BIOA Comparison
CBFV vs BIOA Comparison
Compare CBFV & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- BIOA
- Stock Information
- Founded
- CBFV 1901
- BIOA 2015
- Country
- CBFV United States
- BIOA United States
- Employees
- CBFV N/A
- BIOA N/A
- Industry
- CBFV Major Banks
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- BIOA Health Care
- Exchange
- CBFV Nasdaq
- BIOA Nasdaq
- Market Cap
- CBFV 153.2M
- BIOA 155.2M
- IPO Year
- CBFV N/A
- BIOA 2024
- Fundamental
- Price
- CBFV $33.40
- BIOA $5.00
- Analyst Decision
- CBFV Buy
- BIOA Hold
- Analyst Count
- CBFV 2
- BIOA 4
- Target Price
- CBFV $35.50
- BIOA $5.67
- AVG Volume (30 Days)
- CBFV 7.6K
- BIOA 180.2K
- Earning Date
- CBFV 10-24-2025
- BIOA 11-06-2025
- Dividend Yield
- CBFV 2.99%
- BIOA N/A
- EPS Growth
- CBFV N/A
- BIOA N/A
- EPS
- CBFV 2.15
- BIOA N/A
- Revenue
- CBFV $50,822,000.00
- BIOA $3,863,000.00
- Revenue This Year
- CBFV $10.53
- BIOA N/A
- Revenue Next Year
- CBFV $10.65
- BIOA N/A
- P/E Ratio
- CBFV $15.57
- BIOA N/A
- Revenue Growth
- CBFV N/A
- BIOA N/A
- 52 Week Low
- CBFV $26.01
- BIOA $2.88
- 52 Week High
- CBFV $33.98
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- CBFV 61.01
- BIOA 59.80
- Support Level
- CBFV $32.16
- BIOA $4.68
- Resistance Level
- CBFV $33.44
- BIOA $5.09
- Average True Range (ATR)
- CBFV 0.65
- BIOA 0.24
- MACD
- CBFV -0.04
- BIOA 0.01
- Stochastic Oscillator
- CBFV 75.85
- BIOA 80.36
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.